Lician Pro · $19.99/mo or $149/yr · AAPL vs MSFT
Aptevo Therapeutics Inc (APVO) SEC filings
Aptevo Therapeutics Inc (APVO) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Latest reported APVO revenue for 2022-12-31 was $3.1M. Net income was $8.0M. APVO currently screens at market cap $9.9M. The APVO filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what Aptevo Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
Earnings & events
All eventsEvent insights for APVO — what management said, what changed, and why it matters.
Recent filings
APVO SEC filings FAQ
What is the latest APVO SEC filing?
The latest cached Aptevo Therapeutics Inc (APVO) filing on this page is 8-K · Oct 14, 2026. Filings: https://lician.com/sec/apvo
What is the latest APVO filing accession number?
The latest cached Aptevo Therapeutics Inc (APVO) accession number on this page is 0001193125-26-421076. Filing: https://lician.com/sec/apvo/0001193125-26-421076
Which item codes are on the latest APVO filing?
Cached item codes on the latest Aptevo Therapeutics Inc (APVO) 8-K are 8.01, 9.01.
How many APVO SEC filings are listed on this page?
This page lists 7 cached Aptevo Therapeutics Inc (APVO) SEC filings. Filings: https://lician.com/sec/apvo
What events are listed on the APVO SEC page?
Cached event headlines on this Aptevo Therapeutics Inc (APVO) SEC page: "APVO earnings". Events: https://lician.com/sec/apvo
What are APVO's latest revenue and net income?
Latest cached Aptevo Therapeutics Inc (APVO) revenue for Dec 31, 2022 was $3.1M. Net income was $8.0M. Statements: https://lician.com/financials/apvo